Fiscal Year (FY) 2019 Funding Opportunity, 58779-58780 [2018-25349]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 225 / Wednesday, November 21, 2018 / Notices
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: November 14, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–25355 Filed 11–20–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Meetings
khammond on DSK30JT082PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Conference Grants in Support of Heart, Lung,
and Blood Research.
Date: December 11–12, 2018.
Time: 8:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Room 7296, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Stephanie J. Webb, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6701
Rockledge Drive, Room 7196, Bethesda, MD
20892, 301–287–7332, stephanie.webb@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: November 15, 2018.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–25353 Filed 11–20–18; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
16:08 Nov 20, 2018
Jkt 247001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Chronic Neurodegenerative
Diseases.
Date: December 11, 2018.
Time: 1:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Seetha Bhagavan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5194,
MSC 7846, Bethesda, MD 20892, (301) 237–
9838, bhagavas@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: November 15, 2018.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–25356 Filed 11–20–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Fiscal Year (FY) 2019 Funding
Opportunity
Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice of intent to award a
single source grant to the Community
Anti-Drug Coalitions of America
(CADCA).
AGENCY:
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
58779
This notice is to inform the
public that the Substance Abuse and
Mental Health Services Administration
(SAMHSA) intends to award $500,000
(total costs) for up to five years to
CADCA for the National Anti-Drug
Coalitions Training and Workforce
Development Grant. Under this
initiative, CADCA will provide training
to state and community prevention
leaders, including members of anti-drug
community coalitions from around the
country who are committed to
addressing the evolving needs of the
behavioral health field, and promote
workforce development. Training and
workforce development activities
supported through this grant include
SAMHSA’s Prevention Day, the CADCA
National Leadership Forum, and
CADCA’s Mid-Year Training Institute.
These activities aim to disseminate
knowledge and transfer state-of-the-art
information, assisting state and
community leaders in developing and
implementing evidence-based programs,
practices, and policies aligned with the
21st Century Cures Act, the
Comprehensive Addition and Recovery
Act, the President’s Commission on
combating drug addiction and the
opioid crisis, and other national
substance abuse prevention goals,
outcomes, and efforts, including
underage drinking prevention. This is
not a formal request for applications.
Assistance will be provided only to
CADCA based on the receipt of a
satisfactory application that is approved
by an independent review group.
Funding Opportunity Title: SP–19–
002.
Catalog of Federal Domestic
Assistance (CFDA) Number: 93.243.
Authority: Section 516 of the Public
Health Services Act, as amended.
SUMMARY:
Justification
Eligibility for this award is limited to
CADCA. The purpose of this grant to
provide training and workforce
development for thousands of members
of community coalitions dedicated to
preventing substance abuse through a
national leadership workforce
development and training event.
CADCA is the only national
organization that has special expertise
and unique broad, national-level
experience in working with community
anti-drug coalitions. For more than 22
years, coalitions and coalition
leadership have turned to CADCA to
obtain the assistance they need to
implement, operate, and sustain
effective local community anti-drug
strategies. CADCA will take advantage
of the resources of multiple agencies
located throughout the federal, state and
E:\FR\FM\21NON1.SGM
21NON1
58780
Federal Register / Vol. 83, No. 225 / Wednesday, November 21, 2018 / Notices
local governments, philanthropies, and
universities to bring the best available
knowledge, information, and technology
to local community anti-drug coalitions
working to prevent and reduce drug use
among the youth of America. CADCA is
the only identified organization with the
required experience and national reach
to over 5,000 identified anti-drug
coalitions across the country.
Significant investments were made over
the years to support this program with
outstanding results. CADCA has long
been recognized in communities as well
as states throughout the nation for the
technical support it has provided to
anti-drug coalitions. As such, it is
uniquely qualified and positioned to
carry out the requirements of this
announcement.
Contact: Odessa Crocker, Substance
Abuse and Mental Health Services
Administration, 5600 Fishers Lane,
Rockville, MD 20857; telephone: (240)
276–1078; email: Odessa.Crocker@
samhsa.hhs.gov.
Dated: November 15, 2018.
Carlos Castillo,
Committee Management Officer.
[FR Doc. 2018–25349 Filed 11–20–18; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No. USCG–2018–0792]
Collection of Information Under
Review by Office of Management and
Budget; OMB Control Number: 1625–
0035
Coast Guard, DHS.
Thirty-day notice requesting
comments.
AGENCY:
ACTION:
In compliance with the
Paperwork Reduction Act of 1995 the
U.S. Coast Guard is forwarding an
Information Collection Request (ICR), to
the Office of Management and Budget
(OMB), Office of Information and
Regulatory Affairs (OIRA), requesting an
extension of its approval for a collection
of information regarding: 1625–0035,
Title 46 CFR Subchapter Q: Lifesaving,
Electrical, Engineering and Navigation
Equipment, Construction and Materials
& Marine Sanitation Devices (33 CFR
part 159); without change. Our ICR
describes the information we seek to
collect from the public. Review and
comments by OIRA ensure we only
impose paperwork burdens
commensurate with our performance of
duties.
khammond on DSK30JT082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:08 Nov 20, 2018
Jkt 247001
Comments must reach the Coast
Guard and OIRA on or before December
21, 2018.
ADDRESSES: You may submit comments
identified by Coast Guard docket
number [USCG–2018–0792] to the Coast
Guard using the Federal eRulemaking
Portal at https://www.regulations.gov.
Alternatively, you may submit
comments to OIRA using one of the
following means:
(1) Email: dhsdeskofficer@
omb.eop.gov.
(2) Mail: OIRA, 725 17th Street NW,
Washington, DC 20503, attention Desk
Officer for the Coast Guard.
A copy of the ICR is available through
the docket on the internet at https://
www.regulations.gov. Additionally,
copies are available from: Commandant
(CG–612), Attn: Paperwork Reduction
Act Manager, U.S. Coast Guard, 2703
Martin Luther King Jr. Ave. SE, STOP
7710, Washington, DC 20593–7710.
FOR FURTHER INFORMATION CONTACT: Mr.
Anthony Smith, Office of Information
Management, telephone 202–475–3532,
or fax 202–372–8405, for questions on
these documents.
SUPPLEMENTARY INFORMATION: In
compliance with the Paperwork
Reduction Act of 1995 the U.S. Coast
Guard is forwarding an ICR to OMB,
OIRA, requesting an extension of its
approval for a collection of the
following information: 1625–0035, Title
46 CFR Subchapter Q Lifesaving,
Electrical, Engineering and Navigation
Equipment, Construction and Materials
& Marine Sanitation Devices (33 CFR
part 159) without change.
DATES:
Public Participation and Request for
Comments
This Notice relies on the authority of
the Paperwork Reduction Act of 1995;
44 U.S.C. Chapter 35, as amended. An
ICR is an application to OIRA seeking
the approval, extension, or renewal of a
Coast Guard collection of information
(Collection). The ICR contains
information describing the Collection’s
purpose, the Collection’s likely burden
on the affected public, an explanation of
the necessity of the Collection, and
other important information describing
the Collection. There is one ICR for each
Collection.
The Coast Guard invites comments on
whether this ICR should be granted
based on the Collection being necessary
for the proper performance of
Departmental functions. In particular,
the Coast Guard would appreciate
comments addressing: (1) The practical
utility of the Collection; (2) the accuracy
of the estimated burden of the
Collection; (3) ways to enhance the
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
quality, utility, and clarity of
information subject to the Collection;
and (4) ways to minimize the burden of
the Collection on respondents,
including the use of automated
collection techniques or other forms of
information technology. These
comments will help OIRA determine
whether to approve the ICR referred to
in this Notice.
We encourage you to respond to this
request by submitting comments and
related materials. Comments to Coast
Guard or OIRA must contain the OMB
Control Number of the ICR. They must
also contain the docket number of this
request, [USCG–2018–0792], and must
be received by December 21, 2018
Submitting Comments
We encourage you to submit
comments through the Federal
eRulemaking Portal at https://
www.regulations.gov. If your material
cannot be submitted using https://
www.regulations.gov, contact the person
in the FOR FURTHER INFORMATION
CONTACT section of this document for
alternate instructions. Documents
mentioned in this notice, and all public
comments, are in our online docket at
https://www.regulations.gov and can be
viewed by following that website’s
instructions. Additionally, if you go to
the online docket and sign up for email
alerts, you will be notified when
comments are posted.
We accept anonymous comments. All
comments received will be posted
without change to https://
www.regulations.gov and will include
any personal information you have
provided. For more about privacy and
the docket, you may review a Privacy
Act notice regarding the Federal Docket
Management System in the March 24,
2005, issue of the Federal Register (70
FR 15086).
OIRA posts its decisions on ICRs
online at https://www.reginfo.gov/
public/do/PRAMain after the comment
period for each ICR. An OMB Notice of
Action on each ICR will become
available via a hyperlink in the OMB
Control Number: 1625–0035.
Previous Request for Comments
This request provides a 30-day
comment period required by OIRA. The
Coast Guard published the 60-day
notice (83 FR 45267, September 6, 2018)
required by 44 U.S.C. 3506(c)(2). That
notice elicited no comments.
Accordingly, no changes have been
made to the Collections.
Information Collection Request
Title: Title 46 CFR Subchapter Q:
Lifesaving, Electrical, Engineering and
E:\FR\FM\21NON1.SGM
21NON1
]]>Agencies
[Federal Register Volume 83, Number 225 (Wednesday, November 21, 2018)]
[Notices]
[Pages 58779-58780]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-25349]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Fiscal Year (FY) 2019 Funding Opportunity
AGENCY: Substance Abuse and Mental Health Services Administration, HHS.
ACTION: Notice of intent to award a single source grant to the
Community Anti-Drug Coalitions of America (CADCA).
-----------------------------------------------------------------------
SUMMARY: This notice is to inform the public that the Substance Abuse
and Mental Health Services Administration (SAMHSA) intends to award
$500,000 (total costs) for up to five years to CADCA for the National
Anti-Drug Coalitions Training and Workforce Development Grant. Under
this initiative, CADCA will provide training to state and community
prevention leaders, including members of anti-drug community coalitions
from around the country who are committed to addressing the evolving
needs of the behavioral health field, and promote workforce
development. Training and workforce development activities supported
through this grant include SAMHSA's Prevention Day, the CADCA National
Leadership Forum, and CADCA's Mid-Year Training Institute. These
activities aim to disseminate knowledge and transfer state-of-the-art
information, assisting state and community leaders in developing and
implementing evidence-based programs, practices, and policies aligned
with the 21st Century Cures Act, the Comprehensive Addition and
Recovery Act, the President's Commission on combating drug addiction
and the opioid crisis, and other national substance abuse prevention
goals, outcomes, and efforts, including underage drinking prevention.
This is not a formal request for applications. Assistance will be
provided only to CADCA based on the receipt of a satisfactory
application that is approved by an independent review group.
Funding Opportunity Title: SP-19-002.
Catalog of Federal Domestic Assistance (CFDA) Number: 93.243.
Authority: Section 516 of the Public Health Services Act, as
amended.
Justification
Eligibility for this award is limited to CADCA. The purpose of this
grant to provide training and workforce development for thousands of
members of community coalitions dedicated to preventing substance abuse
through a national leadership workforce development and training event.
CADCA is the only national organization that has special expertise and
unique broad, national-level experience in working with community anti-
drug coalitions. For more than 22 years, coalitions and coalition
leadership have turned to CADCA to obtain the assistance they need to
implement, operate, and sustain effective local community anti-drug
strategies. CADCA will take advantage of the resources of multiple
agencies located throughout the federal, state and
[[Page 58780]]
local governments, philanthropies, and universities to bring the best
available knowledge, information, and technology to local community
anti-drug coalitions working to prevent and reduce drug use among the
youth of America. CADCA is the only identified organization with the
required experience and national reach to over 5,000 identified anti-
drug coalitions across the country. Significant investments were made
over the years to support this program with outstanding results. CADCA
has long been recognized in communities as well as states throughout
the nation for the technical support it has provided to anti-drug
coalitions. As such, it is uniquely qualified and positioned to carry
out the requirements of this announcement.
Contact: Odessa Crocker, Substance Abuse and Mental Health Services
Administration, 5600 Fishers Lane, Rockville, MD 20857; telephone:
(240) 276-1078; email: [email protected].
Dated: November 15, 2018.
Carlos Castillo,
Committee Management Officer.
[FR Doc. 2018-25349 Filed 11-20-18; 8:45 am]
BILLING CODE 4162-20-P
